Alex Mohr, PhD

Alex is the Director of Microbiomics at Theriome, where he spearheads initiatives that integrate multi-omics and systems biology approaches to advance precision medicine. As a co-founder of Theriome, Alex has been instrumental in pioneering research on the gut microbiome, leveraging bioinformatics and multi-omic analyses to illuminate the intricate relationships between microbiota, host metabolism, and health outcomes. His work emphasizes the potential of microbiome-based interventions to enhance individual resilience and inform therapeutic strategies.

In addition to his role at Theriome, Alex serves on the board of the American Board of Precision Medicine (ABOPM) as the Director of Microbiomics, supporting the transition of precision medicine from theory to practice. He is also a postdoctoral fellow funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), specializing in gut microbiome research that bridges microbiology, nutrition, and functional medicine. Alex is passionate about translating emerging scientific advances into practical applications for clinicians.